These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 30298551)

  • 1. Power and sample size requirements for GEE analyses of cluster randomized crossover trials.
    Li F; Forbes AB; Turner EL; Preisser JS
    Stat Med; 2019 Feb; 38(4):636-649. PubMed ID: 30298551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size determination for GEE analyses of stepped wedge cluster randomized trials.
    Li F; Turner EL; Preisser JS
    Biometrics; 2018 Dec; 74(4):1450-1458. PubMed ID: 29921006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalized estimating equations in cluster randomized trials with a small number of clusters: Review of practice and simulation study.
    Huang S; Fiero MH; Bell ML
    Clin Trials; 2016 Aug; 13(4):445-9. PubMed ID: 27094487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the cluster randomised crossover design: a graphical illustraton of the components of variation and a sample size tutorial.
    Arnup SJ; McKenzie JE; Hemming K; Pilcher D; Forbes AB
    Trials; 2017 Aug; 18(1):381. PubMed ID: 28810895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small sample performance of bias-corrected sandwich estimators for cluster-randomized trials with binary outcomes.
    Li P; Redden DT
    Stat Med; 2015 Jan; 34(2):281-96. PubMed ID: 25345738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Power considerations for generalized estimating equations analyses of four-level cluster randomized trials.
    Wang X; Turner EL; Preisser JS; Li F
    Biom J; 2022 Apr; 64(4):663-680. PubMed ID: 34897793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GEEMAEE: A SAS macro for the analysis of correlated outcomes based on GEE and finite-sample adjustments with application to cluster randomized trials.
    Zhang Y; Preisser JS; Li F; Turner EL; Toles M; Rathouz PJ
    Comput Methods Programs Biomed; 2023 Mar; 230():107362. PubMed ID: 36709555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and analysis considerations for cohort stepped wedge cluster randomized trials with a decay correlation structure.
    Li F
    Stat Med; 2020 Feb; 39(4):438-455. PubMed ID: 31797438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cluster randomised crossover trials with binary data and unbalanced cluster sizes: application to studies of near-universal interventions in intensive care.
    Forbes AB; Akram M; Pilcher D; Cooper J; Bellomo R
    Clin Trials; 2015 Feb; 12(1):34-44. PubMed ID: 25475880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cluster randomized crossover trial: The effects of attrition in the AB/BA design and how to account for it in sample size calculations.
    Moerbeek M
    Clin Trials; 2020 Aug; 17(4):420-429. PubMed ID: 32191129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing individually randomized group treatment trials with repeated outcome measurements using generalized estimating equations.
    Wang X; Turner EL; Li F
    Stat Med; 2024 Jan; 43(2):358-378. PubMed ID: 38009329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finite-sample corrected generalized estimating equation of population average treatment effects in stepped wedge cluster randomized trials.
    Scott JM; deCamp A; Juraska M; Fay MP; Gilbert PB
    Stat Methods Med Res; 2017 Apr; 26(2):583-597. PubMed ID: 25267551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Power and sample size calculations for cluster randomized trials with binary outcomes when intracluster correlation coefficients vary by treatment arm.
    Kennedy-Shaffer L; Hughes MD
    Clin Trials; 2022 Feb; 19(1):42-51. PubMed ID: 34879711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and analysis of a 2-year parallel follow-up of repeated ivermectin mass drug administrations for control of malaria: Small sample considerations for cluster-randomized trials with count data.
    Jackson CL; Colborn K; Gao D; Rao S; Slater HC; Parikh S; Foy BD; Kittelson J
    Clin Trials; 2021 Oct; 18(5):582-593. PubMed ID: 34218684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A general method for calculating power for GEE analysis of complete and incomplete stepped wedge cluster randomized trials.
    Zhang Y; Preisser JS; Turner EL; Rathouz PJ; Toles M; Li F
    Stat Methods Med Res; 2023 Jan; 32(1):71-87. PubMed ID: 36253078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size calculation in three-level cluster randomized trials using generalized estimating equation models.
    Liu J; Colditz GA
    Stat Med; 2020 Oct; 39(24):3347-3372. PubMed ID: 32720717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size considerations for GEE analyses of three-level cluster randomized trials.
    Teerenstra S; Lu B; Preisser JS; van Achterberg T; Borm GF
    Biometrics; 2010 Dec; 66(4):1230-7. PubMed ID: 20070297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A note on sample size calculations for cluster randomised crossover trials with a fixed number of clusters.
    Kelly TL; Pratt N
    Stat Med; 2019 Aug; 38(18):3342-3345. PubMed ID: 31069820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A flexible sample size solution for longitudinal and crossover cluster randomized trials with continuous outcomes.
    Wang J; Cao J; Zhang S; Ahn C
    Contemp Clin Trials; 2021 Oct; 109():106543. PubMed ID: 34450326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.